Lupin launches biosimilar cetuximab in pact with Enzene

Cetuximab has received approval from the Drug Controller General of India (DCGI) for its effectiveness in treating head and neck cancer

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9otIiNp
via IFTTT